Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Telaprevir”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01718158
What this trial is testing

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 444
Post-approval studies (Phase 4)Ended earlyNCT01592006
What this trial is testing

Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients

Who this might be right for
Hepatitis C
University of Chicago 3
Testing effectiveness (Phase 2)Study completedNCT00336479
What this trial is testing

Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C

Who this might be right for
Chronic Hepatitis C
Vertex Pharmaceuticals Incorporated 263
Post-approval studies (Phase 4)WithdrawnNCT01766115
What this trial is testing

Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers

Who this might be right for
Viral Hepatitis C
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT01600976
What this trial is testing

Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Janssen Infectious Diseases BVBA 24
Large-scale testing (Phase 3)Ended earlyNCT01459913
What this trial is testing

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 239
Testing effectiveness (Phase 2)Study completedNCT00535847
What this trial is testing

A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 117
Early research (Phase 1)Study completedNCT00958152
What this trial is testing

Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 30
Testing effectiveness (Phase 2)UnknownNCT01872936
What this trial is testing

Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Santaris Pharma A/S 20
Post-approval studies (Phase 4)Study completedNCT01743521
What this trial is testing

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 14
Early research (Phase 1)Study completedNCT01704521
What this trial is testing

Viral Kinetics in HCV Clearance in Subjects With Hemophilia

Who this might be right for
Chronic Hepatitis CHemophilia
Kenneth Sherman 5
Early research (Phase 1)Study completedNCT01646489
What this trial is testing

Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

Who this might be right for
Hepatitis CChronic Hepatitis C
Santaris Pharma A/S 5
Not applicableStudy completedNCT02004379
What this trial is testing

Register of Telaprevir and Boceprevir in Routine Clinical Practice

Who this might be right for
Hepatitis C
Fundación Pública Andaluza Progreso y Salud 1,553
Testing effectiveness (Phase 2)Study completedNCT01648140
What this trial is testing

Dose Ranging of GSK2336805 in Combination Therapy

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 286
Large-scale testing (Phase 3)Study completedNCT00627926
What this trial is testing

Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 1,095
Large-scale testing (Phase 3)Study completedNCT01500616
What this trial is testing

Telaprevir Open-Label Study in Co-Infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen-Cilag International NV 122
Testing effectiveness (Phase 2)Ended earlyNCT01701063
What this trial is testing

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 42
Early research (Phase 1)Study completedNCT01582035
What this trial is testing

Study to Examine Multiple Doses of TMC647055 in Combination With Telaprevir

Who this might be right for
Hepatitis C
Janssen R&D Ireland 7
Not applicableStudy completedNCT01544582
What this trial is testing

Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)

Who this might be right for
Hepatitis C Chronic
Merck Sharp & Dohme LLC 713
Early research (Phase 1)Study completedNCT00251199
What this trial is testing

VX-950 and Peginterferon for Hepatitis C

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation